Pluri Inc

About

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18.

The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.

Growth

Pluri Biotech Ltd. is a well-established company that has been operating since 2003, positioning itself as a global leader in 3D cell-expansion technology. With over a decade of experience, the company has shown significant growth and development in the pharmaceutical industry. Pluri's technology has the potential to create solutions for various industries beyond pharma, including food tech and agri-tech. The company is at a scale-up stage, focusing on expanding its reach and impact across different verticals.

Achievements

Pluri Biotech Ltd. has achieved several significant milestones in its history. Since its founding in 2003, the company has developed cutting-edge cell expansion platforms that have accelerated the development of pharmaceutical product candidates. Pluri's technology has been recognized for its efficiency and cost-effectiveness in growing various cell types, from plants to animals and humans. The company's focus on harnessing the wisdom of nature to develop next-generation products showcases its commitment to innovation and sustainability in global wellbeing.

Case Studies

Pluri Biotech Ltd. has been involved in several notable case studies showcasing the impact of its cell expansion technologies. By leveraging its 3D platforms, the company has successfully grown cells to develop cutting-edge products in the pharmaceutical industry. These case studies highlight the valuable contribution of Pluri's technology to the advancement of medical research and product innovation. The company's innovative solutions have the potential to revolutionize not only the pharma sector but also other industries such as food tech and agri-tech.

Socials

company logo
CEO
Founded

-

Operating Status

Active

Industry

Health Care/Life Sciences

headquarters
Address

MATAM Advanced Technology Park Building No. 5 Haifa HA 3508409 Israel...

Country

Israel

Employees

134

Key People

Rami Avraham Levi (Independent Director)

Yaky Yanay (President, Chief Executive Officer & Director)

Liat Zalts (Chief Financial Officer & Treasurer)

Revenue

287,000

Operating Income

Stock Price

$4.37


Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success

Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.

Why Choose a VDC for Your Company?

1. Cost Optimization:

Save up to 70% on operational costs by leveraging remote teams and streamlined processes.

2. Expert Access:

Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.

3. Scalable Teams:

Scale your team as business needs evolve, from initial project setup to long-term support.

4. Accelerated Timelines:

Leverage 24/7 global teams to reduce project delays and speed up implementation.

5. Continuous Support:

Ensure uninterrupted business performance with ongoing maintenance and updates.

Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us

Book A Meeting To Setup Your VDCovertime

Welcome to AiDOOS Wiki

AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.


Pluri Inc

company logo

About Pluri Inc

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18.

The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.


Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success

Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.

Why Choose a VDC for Your Company?

1. Cost Optimization:

Save up to 70% on operational costs by leveraging remote teams and streamlined processes.

2. Expert Access:

Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.

3. Scalable Teams:

Scale your team as business needs evolve, from initial project setup to long-term support.

4. Accelerated Timelines:

Leverage 24/7 global teams to reduce project delays and speed up implementation.

5. Continuous Support:

Ensure uninterrupted business performance with ongoing maintenance and updates.

Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us

Book A Meeting To Setup Your VDCovertime
overtime